No abstract

SUMMARY BackgroundThe long-term efficacy of infliximab as rescue therapy in steroid-refractory ulcerative colitis is not well described.

No abstract

A significant proportion of patients with both clinical and histological diagnosis of NAFLD develop metabolic problems soon after diagnosis. These patients should be screened regularly for metabolic disorders.

SUMMARY BackgroundRescue therapy with infliximab (IFX) has been proven effective in a steroidrefractory attack of ulcerative colitis (UC). The long-term efficacy is not well described.